Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Cartridges with samples for GeneXpert test system used for rapid TB and rifampicin-resistance diagnostics. Photo credit: Lana Abramova
Press release
Press release |
23 April 2024
Diagnostics

As Danaher reports quarterly earnings and increased market share for Cepheid’s GeneXpert medical tests, MSF calls on corporation to drop all test prices to $5 for low- and middle-income countries

2 min
Hassan Abdedine, vaccinator of the Ministry of Public Health of Chad, on a vaccination site set up by MSF teams in Dini, Batha province, Chad. Photo credit: MSF/Johnny Vianney Bissakonou
Press release
Press release |
15 April 2024
Vaccines

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

3 min
A close-up of Siwar holding her insulin pen. Siwar has type 1 diabetes and received her insulin pen from the MSF clinic in Arsal. Drawing on Siwar's experience, her father explains to how insulin pens make life easier for diabetic kids. Photo credit: Carmen Yahchouchi/MSF
Press release
Press release |
27 March 2024
Diabetes

New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens

6 min
Time for $5
Press release
Press release |
22 March 2024
Diagnostics

‘Time for Five’ coalition launches global petition targeting medical test maker Cepheid and parent corporation Danaher

6 min
Medical staff providing treatment in MSF-supported Bolomba Ebola treatment center, Equateur province, DRC, August 2020 Photo credit: Franck Ngonga/MSF
Press release
Press release |
18 March 2024
Tropical & neglected diseases

MSF calls for emergency stockpile of Ebola treatments ten years after world’s deadliest outbreak

4 min
6th October 2010: Wednesday in New Delhi, patients and activists stage a DIE-IN to protest at talks today between the European Union and the Indian government over a free trade agreement that could end production of life-saving affordable medicines for millions in need in developing countries. Photo credit: Suraj Mishra
Press release
Press release |
12 March 2024
Intellectual property and trade
SwitzerlandIndia

MSF response to signing of EFTA-India trade agreement

2 min
A close-up photo shows pills in the hand of an MDR TB patient taking his Direct Observation Treatment Short Course (DOTs) medication at the Nhlangano TB Ward supported by MSF. Photo credit: Giorgos Moutafis
Press release
Press release |
29 February 2024
Intellectual property and trade

EU must drop all intellectual property provisions that go beyond WTO requirements in trade negotiations with India, as recommended in today’s SIA report

5 min
Thousands of demonstrators took to the streets in Delhi once again on 2 March 2011, in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines.Thousands of demonstrators took to the streets in Delhi once again on 2 March in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines. Photo credit: Mudit Mathur
Press release
Press release |
15 February 2024
Intellectual property and trade
EuropeIndia

MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions

2 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury